Search

everythinglearnresearchcommunity

for

Search:↓

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

There's a growing resistance to the antibiotic mupirocin in children's skin infections caused by MRSA in New York.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.

The secretions of mesenchymal stem cells could be used for healing without using the cells themselves.

The immune system plays a key role in tissue repair, affecting both healing quality and regenerative ability.

Skin cells produce and activate vitamin D, which regulates skin functions and supports hair growth.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Stress can cause hair loss by negatively affecting hair follicles and this effect might be reversed with specific treatments.

Dermal Papilla cells are a promising tool for evaluating hair growth treatments.

Engineered exosomes show promise for improving wound healing but face challenges in clinical use.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Different scaffold patterns improve wound healing and immune response in mouse skin, with aligned patterns being particularly effective.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Adequate testosterone is crucial for men's health and quality of life, but its decline with age needs more research.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

Injected human hair follicle cells can create new, small hair follicles in skin cultures.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

A special hydrogel helps heal skin without scars and regrows hair.

Mesenchymal stem cells help improve wound healing by reducing inflammation and promoting skin cell growth and movement.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

Activating Notch in adult skin causes T cells and neural crest cells to gather, leading to skin issues.

Minoxidil affects cell growth in two ways: low doses increase growth, while high doses slow it down and can be toxic.

Certain fats in the skin help control inflammation and health, and changing these fats through diet or supplements might treat skin inflammation.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.